UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

The lancet oncology, 2009-05, Vol.10 (5), p.489-500

2009

Volltextzugriff (PDF)

Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor

Journal of clinical virology, 2016-11, Vol.84, p.24-26

2016

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit

Journal of critical care, 2015-10, Vol.30 (5), p.1107-1113

2015

Volltextzugriff (PDF)

Intralesional Rituximab

Ophthalmology (Rochester, Minn.), 2011, Vol.118 (1), p.24-28

2011

Volltextzugriff (PDF)

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)

The Lancet infectious diseases, 2019-06, Vol.19 (6), p.e200-e212

2019

Volltextzugriff (PDF)

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

The Lancet infectious diseases, 2019-08, Vol.19 (8), p.e260-e272

2019

Volltextzugriff (PDF)

Strong humoral response after Covid‐19 vaccination correlates with the common HLA allele A03:01 and protection from breakthrough infection

HLA, 2024-03, Vol.103 (3), p.e15421-n/a

2024

Volltextzugriff (PDF)

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

The Lancet infectious diseases, 2019-06, Vol.19 (6), p.e188-e199

2019

Volltextzugriff (PDF)

Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine

HLA, 2022-03, Vol.99 (3), p.183-191

2022

Volltextzugriff (PDF)

Is SARS-CoV-2 screening still necessary before hematopoietic stem cell donation? Observations from a single center and review of the literature

Transfusion and apheresis science, 2022-10, Vol.61 (5), p.103448-103448, Article 103448

2022

Volltextzugriff (PDF)

Plasma cell-directed therapy and anti-HLA antibody production: A successful combination?

Current research in translational medicine, 2023-04, Vol.71 (2), p.103391-103391, Article 103391

2023

Volltextzugriff (PDF)

Diagnostic, prophylaxie et prise en charge thérapeutique de la GVH aiguë : recommandations de la SFGM-TC

Bulletin du cancer, 2023-02, Vol.110 (2), p.S79-S87

2023

Volltextzugriff (PDF)

Diagnostic, prophylaxie et prise en charge thérapeutique de la GVH aiguë : recommandations de la SFGM-TC

Bulletin du cancer, 2022-11, Vol.110, p.S79-S87

2022

Volltextzugriff (PDF)

Choix d’un donneur non apparenté en vue d’une allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Bulletin du cancer, 2024-02, Vol.111 (2), p.S1-S13

2024

Volltextzugriff (PDF)

Diagnosis, prophylaxis and therapeutic management of acute GVH: Guidelines from the SFGM-TC

Bulletin du cancer, 2023-02, Vol.110 (2S), p.S79

2023

Volltextzugriff (PDF)

Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban

Thrombosis and haemostasis, 2003-02, Vol.89 (2), p.348

2003

Volltextzugriff (PDF)

Unrelated donor selection for allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Bulletin du cancer, 2024-02, Vol.111 (2S), p.S1

2024

Volltextzugriff (PDF)

Intralesional Rituximab: A New Therapeutic Approach for Patients with Conjunctival Lymphomas

Ophthalmology (Rochester, Minn.), 2011, Vol.118 (1), p.24-28

2011

Volltextzugriff (PDF)

Définition et standardisation des bilans d’histocompatibilité en fonction du parcours du patient et du type de donneur : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) et de la Société Francophone d’Histocompatibilité et Immunogénétique (SFHI)

Bulletin du cancer, 2021-12, Vol.108 (12), p.S45-S52

2021

Volltextzugriff (PDF)

Low content of clonogenic progenitors on day+18 is associated with acute graft-versus-host disease and predicts transplant-related mortality

Experimental hematology, 2021-03, Vol.95, p.58-67.e4

2021

Volltextzugriff (PDF)

Desensitization with plasma exchange in a patient with human leukocyte antigen donor‐specific antibodies before T‐cell–replete haploidentical transplantation

Transfusion (Philadelphia, Pa.), 2016-05, Vol.56 (5), p.1096-1100

2016

Volltextzugriff (PDF)

Definition and standardization of histocompatibility requests depending on patient course and donor type: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society of Histocompatibility and Immunogenetics (SFHI)

Bulletin du cancer, 2021-12, Vol.108 (12S), p.S45

2021

Volltextzugriff (PDF)

The number of HLA confirmatory tests during unrelated donor search as a driver for the evaluation of back-up haploidentical donor(s)

Transfusion and apheresis science, 2020-08, Vol.59 (4), p.102766-102766, Article 102766

2020

Volltextzugriff (PDF)

Correlation analysis between virtual and Complement-Dependent-Cytotoxicity crossmatch in a monocenter retrospective series of 118 allografted patients

Current research in translational medicine, 2021-05, Vol.69 (2), p.103287, Article 103287

2021

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(54)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(40)
Science & Technology
(40)
Humans
(34)
Hematology
(24)
Adult
(15)
Middle Aged
(15)
Female
(14)
Male
(14)
Oncology
(14)
Transplantation, Homologous
(14)
Aged
(11)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(10)
Hematopoietic Stem Cell Transplantation
(9)
Retrospective Studies
(7)
Transplantation Conditioning - Methods
(7)
Treatment Outcome
(7)
Adolescent
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Graft Vs Host Disease - Prevention & Control
(6)
Hla
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor

Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit

Intralesional Rituximab

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Strong humoral response after Covid‐19 vaccination correlates with the common HLA allele A03:01 and protection from breakthrough infection

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7)

Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine

Is SARS-CoV-2 screening still necessary before hematopoietic stem cell donation? Observations from a single center and review of the literature

Plasma cell-directed therapy and anti-HLA antibody production: A successful combination?

Diagnostic, prophylaxie et prise en charge thérapeutique de la GVH aiguë : recommandations de la SFGM-TC

Diagnostic, prophylaxie et prise en charge thérapeutique de la GVH aiguë : recommandations de la SFGM-TC

Choix d’un donneur non apparenté en vue d’une allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Diagnosis, prophylaxis and therapeutic management of acute GVH: Guidelines from the SFGM-TC

Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban

Unrelated donor selection for allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Intralesional Rituximab: A New Therapeutic Approach for Patients with Conjunctival Lymphomas

Low content of clonogenic progenitors on day+18 is associated with acute graft-versus-host disease and predicts transplant-related mortality

Desensitization with plasma exchange in a patient with human leukocyte antigen donor‐specific antibodies before T‐cell–replete haploidentical transplantation

Definition and standardization of histocompatibility requests depending on patient course and donor type: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society of Histocompatibility and Immunogenetics (SFHI)

The number of HLA confirmatory tests during unrelated donor search as a driver for the evaluation of back-up haploidentical donor(s)

Correlation analysis between virtual and Complement-Dependent-Cytotoxicity crossmatch in a monocenter retrospective series of 118 allografted patients

Use of DPB1 T‐cell epitope algorithm among italian transplant centers: A survey on behalf of Associazione Italiana di Immunogenetica e Biologia dei Trapianti

Aktive Filter

Suchergebnisse filtern